Skip to content
PubMed This is a summary of 41 peer-reviewed journal articles Updated
Endocrinology

Ovarian Stromal Hyperthecosis: A Patient Guide

At a Glance

Ovarian stromal hyperthecosis is a rare condition in which ovarian cells produce excess testosterone, often after menopause. Treatment may involve removal of both ovaries or hormone-suppressing medicine, while blood sugar and cardiovascular health still need long-term attention.

Ovarian stromal hyperthecosis, often referred to simply as ovarian hyperthecosis, is a rare but well-documented condition in which the ovaries produce excessive amounts of testosterone. Unlike more common hormonal issues, this condition involves the overgrowth of specialized cells, called luteinized theca cells, deep within the ovary’s supportive tissue. These cells form small clusters that produce high levels of androgens into the bloodstream [1][2].

While it can occur in younger people, this condition is most frequently identified in patients who have already gone through menopause. For those who are postmenopausal, the sudden or progressive appearance of new facial hair, scalp hair thinning, or even a deepening voice can be the first sign that the ovaries have become overactive. Because estrogen levels naturally decline after menopause, the effects of the elevated testosterone become much more prominent [2][3]. Because the testosterone levels in hyperthecosis can be much higher than those seen in other conditions, the physical changes can be quite significant and may occur even years after the menstrual cycle has stopped.

One of the most important aspects of living with this condition is understanding its association with insulin resistance. Research has shown that high levels of insulin in the blood may contribute to and enhance ovarian androgen production. Many patients with hyperthecosis also struggle with associated metabolic conditions like weight gain around the midsection, high blood pressure, or hyperpigmented, velvety patches of skin in areas like the neck or armpits [4][5].

The path to management focuses on two main goals: addressing the hormone production and protecting your long-term health. For many postmenopausal patients, bilateral oophorectomy (the surgical removal of the ovaries) is often recommended as the definitive option, which typically leads to a rapid drop in hormone levels. For others, specialized medications may be used to suppress the ovaries’ hormone signals [4][6]. However, it is important to remember that normalizing your testosterone is only one part of the journey. Because of the strong metabolic link, managing blood sugar and heart health may remain a lifelong priority, even after the hormonal source has been treated [1][7].

Ultimately, a diagnosis of ovarian hyperthecosis is a call to take a comprehensive look at your overall well-being. By addressing both the physical changes driven by hormones and the underlying metabolic risks, you can work toward a future where your body feels more like your own again.

Common questions in this guide

What is ovarian stromal hyperthecosis?
Ovarian stromal hyperthecosis is a rare condition in which specialized cells within the ovaries grow in clusters and make too much testosterone. It is most often recognized after menopause, when high testosterone can cause more noticeable physical changes.
Which symptoms can ovarian hyperthecosis cause?
Possible signs include new facial hair, thinning scalp hair, a deeper voice, and dark, velvety skin patches on the neck or armpits. Some people also have weight gain around the middle or high blood pressure, particularly when insulin resistance is present.
How is ovarian hyperthecosis related to insulin resistance?
High insulin levels may encourage the ovaries to make more androgens, including testosterone. Insulin resistance can occur alongside weight gain around the midsection, high blood pressure, and dark, velvety skin changes, so blood sugar and heart health deserve attention.
How do doctors evaluate ovarian stromal hyperthecosis?
Evaluation may include your symptoms, a physical examination, testosterone and other blood tests, and imaging such as an ultrasound or MRI. Your clinician uses these findings to assess the source of hormone excess and plan the next step.
What treatments are used for ovarian hyperthecosis?
For many postmenopausal patients, bilateral oophorectomy—the surgical removal of both ovaries—is the definitive treatment and typically causes hormone levels to fall quickly. In some cases, specialized medicines may be used to suppress ovarian hormone signals, depending on the person’s situation.
Will treating ovarian hyperthecosis also address metabolic risks?
Treating the ovarian hormone source may normalize testosterone, but it does not necessarily remove the need to manage insulin resistance and cardiovascular risk. Long-term attention to blood sugar, blood pressure, weight, and heart health may still be important after treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How do my testosterone levels compare to the typical ranges seen in this condition?
  2. 2.Does my physical examination or lab work suggest I have significant insulin resistance?
  3. 3.Given my age and symptoms, what is the most appropriate first step in my treatment plan?
  4. 4.What role will imaging, such as an MRI or ultrasound, play in my clinical diagnosis?
  5. 5.How will we monitor my cardiovascular and metabolic health over the long term?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.

    Meczekalski B, Szeliga A, Maciejewska-Jeske M, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021; (37(8)):677-682 doi:10.1080/09513590.2021.1903419.

    PMID: 33759685
  2. 2

    Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis.

    Metzker LS, Ferreira LAC, Borges JCN, et al.

    Case reports in obstetrics and gynecology 2023; (2023()):2783464 doi:10.1155/2023/2783464.

    PMID: 36743832
  3. 3

    Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.

    Czyzyk A, Latacz J, Filipowicz D, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2017; (33(11)):836-839 doi:10.1080/09513590.2017.1337094.

    PMID: 28604129
  4. 4

    Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.

    Mamoojee Y, Ganguri M, Taylor N, Quinton R

    Clinical endocrinology 2018; (88(1)):13-20 doi:10.1111/cen.13492.

    PMID: 28980338
  5. 5

    Ovarian Stromal Hyperplasia: A Rare Cause of Postmenopausal Hyperandrogenism.

    Lozoya Araque T, Monfort Ortiz IR, Martín González JE, et al.

    Journal of menopausal medicine 2020; (26(1)):39-43 doi:10.6118/jmm.19012.

    PMID: 32307950
  6. 6

    Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization.

    Rocha T, Crespo RP, Yance VVR, et al.

    Journal of the Endocrine Society 2019; (3(5)):1087-1096 doi:10.1210/js.2018-00405.

    PMID: 31073547
  7. 7

    Ovarian stromal hyperthecosis: An underestimated virilizing disorder in postmenopausal women.

    Boudaouara O, Sellami A, Roger P

    Annales d'endocrinologie 2025; (86(5)):101800 doi:10.1016/j.ando.2025.101800.

    PMID: 40513985

This page explains ovarian stromal hyperthecosis, its hormone and metabolic effects, and treatment options for educational purposes only. It does not replace medical advice; discuss your testosterone results, imaging, and care plan with your gynecologist or endocrinologist.

Get notified when new evidence is published on ovarian stromal hyperthecosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.